Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

225,331-225,360 of 319,975

filter-aware
22
The scatter plot highlights a specific cluster of compounds (labeled 1 and 2) that were selected by the active learning model despite being outside the typical high-potency/high-score Pareto frontier.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
23
The slide highlights technical infrastructure and R&D capabilities.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
24
The slide uses a process flow diagram to connect target criteria to computational optimization and final project telemetry.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
25
The diagram uses a hub-and-spoke style flow to show data integration, generative design, and iterative refinement.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
26
The slide features a 3D molecular model and a set of circular gauges representing various drug discovery metrics (potency, stability, toxicity, etc.).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
27
The slide highlights technical capabilities in computational chemistry/drug discovery.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
28
The slide uses a pyramid diagram to show a hierarchical process of drug discovery automation.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
29
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
30
The slide depicts a 'flywheel' or 'closed-loop' process architecture for automated scientific research.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
31
DMT cycle = design-make-test cycleExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
32
The slide uses a combination of icons and a process diagram to illustrate the facility's capabilities.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses an isometric technical illustration to depict a modular lab automation setup.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses a before-after framing to contrast traditional chemical synthesis methods with the requirements of AI-driven design.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a process flow diagram at the top to show the workflow stages, followed by three specific hardware solutions.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
36
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a circular process flow to represent the R&D pipeline.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
38
The slide uses a process flow diagram to illustrate a specific patient journey.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
39
Kaplan-Meier survival curves comparing PFS1 (prior treatment) vs PFS2 (study treatment).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
40
The slide uses a linear process flow to explain the study methodology.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
41
The slide uses a complex visual mapping to show drug response across two different biological models (patient samples vs cell lines).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
42
The slide uses a small multiples approach to show dose-response curves for individual patient samples, followed by a summary box plot on the right.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
43
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
44
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
45
The slide features a molecular visualization of the inhibitor.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
46
The slide outlines a standard oncology clinical trial design (dose escalation followed by expansion).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
47
The slide uses a human anatomy diagram to map specific cancer types to their respective organs, providing a visual representation of the addressable market.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
48
The slide uses a biological pathway diagram to explain the mechanism of action and a honeycomb diagram to illustrate market breadth.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
49
The slide uses a three-column layout to define technical requirements for a pharmaceutical product.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
50
The table uses a color-coded heatmap to indicate performance against criteria (green=pass, yellow=minor deviation, red=major deviation).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
51
The slide presents preclinical efficacy data for a CDK7 inhibitor ('617) in ovarian (OVCAR3) and triple-negative breast cancer (HCC70) models.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit